For the control of estrogen-responsive urinary incontinence in ovariohysterectomized female dogs
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor induction of estrus in prepuberal gilts and healthy weaned sows experiencing delayed return to estrus.
LEARN MORE